These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35392973)
1. ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway. Ma Z; Li Z; Wang S; Zhou Z; Liu C; Zhuang H; Zhou Q; Huang S; Zhang C; Hou B J Exp Clin Cancer Res; 2022 Apr; 41(1):130. PubMed ID: 35392973 [TBL] [Abstract][Full Text] [Related]
2. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3. Huang S; Guo H; Cao Y; Xiong J Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474 [TBL] [Abstract][Full Text] [Related]
3. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway. Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma. Li C; Dong Q; Che X; Xu L; Li Z; Fan Y; Hou K; Wang S; Qu J; Xu L; Wen T; Yang X; Qu X; Liu Y BMC Cancer; 2018 Jun; 18(1):681. PubMed ID: 29940895 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14. Du Y; Liu Z; You L; Hou P; Ren X; Jiao T; Zhao W; Li Z; Shu H; Liu C; Zhao Y Cancer Res; 2017 May; 77(10):2661-2673. PubMed ID: 28280038 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation. Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774 [No Abstract] [Full Text] [Related]
7. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice. Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551 [TBL] [Abstract][Full Text] [Related]
8. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. Xie F; Li C; Zhang X; Peng W; Wen T Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891 [TBL] [Abstract][Full Text] [Related]
9. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Gao W; Gu Y; Li Z; Cai H; Peng Q; Tu M; Kondo Y; Shinjo K; Zhu Y; Zhang J; Sekido Y; Han B; Qian Z; Miao Y Oncogene; 2015 Mar; 34(13):1629-40. PubMed ID: 24769899 [TBL] [Abstract][Full Text] [Related]
10. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830 [TBL] [Abstract][Full Text] [Related]
11. The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis. Muniz VP; Barnes JM; Paliwal S; Zhang X; Tang X; Chen S; Zamba KD; Cullen JJ; Meyerholz DK; Meyers S; Davis JN; Grossman SR; Henry MD; Quelle DE Mol Cancer Res; 2011 Jul; 9(7):867-77. PubMed ID: 21636682 [TBL] [Abstract][Full Text] [Related]
12. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport. Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777 [TBL] [Abstract][Full Text] [Related]
13. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028 [TBL] [Abstract][Full Text] [Related]
14. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway. Jiang W; Zhao S; Jiang X; Zhang E; Hu G; Hu B; Zheng P; Xiao J; Lu Z; Lu Y; Ni J; Chen C; Wang X; Yang L; Wan R Cancer Lett; 2016 Feb; 371(2):314-25. PubMed ID: 26683776 [TBL] [Abstract][Full Text] [Related]
15. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976 [TBL] [Abstract][Full Text] [Related]
16. EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT. Zhu F; Dai SN; Xu DL; Hou CQ; Liu TT; Chen QY; Wu JL; Miao Y Biomed Pharmacother; 2020 May; 125():109972. PubMed ID: 32036221 [TBL] [Abstract][Full Text] [Related]
17. Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression. Xu RL; He W; Tang J; Guo W; Zhuang P; Wang CQ; Fu WM; Zhang JF Exp Cell Res; 2018 Feb; 363(2):310-314. PubMed ID: 29366808 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-561-5p Inhibits Cell Proliferation and Invasion by Targeting RAC1 in Pancreatic Ductal Adenocarcinoma. Xi B; Lai M; Zhang W; Wang F Ann Clin Lab Sci; 2022 Mar; 52(2):213-221. PubMed ID: 35414500 [TBL] [Abstract][Full Text] [Related]
19. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b. Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592 [TBL] [Abstract][Full Text] [Related]
20. The Novel SLRP Family Member Lumican Suppresses Pancreatic Cancer Cell Growth. Gao H; Liu C; Ren Q; Zhang L; Qin W; Wang H; Zhang Y Pancreas; 2023 Jan; 52(1):e29-e36. PubMed ID: 37378898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]